HIF-Dependent Hematopoietic Factors Regulate the Development of the Embryonic Vasculature

Developmental Cell

Volumn 11, Issue 1, 2006, Pages 81-92

  Ramírez Bergeron, Diana L ^a   Runge, Anja ^a,b   Adelman, David M ^a   Gohil, Mercy ^a   Simon, M Celeste ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DEVBIO

Indexed keywords

ATAXIN 1; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1BETA; RECOMBINANT VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EXPLANT; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; VASCULARIZATION; WILD TYPE;

ANIMALS; APOPTOSIS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; BLOOD VESSELS; BONE MARROW CELLS; COCULTURE TECHNIQUES; DNA; EMBRYONIC DEVELOPMENT; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RECOMBINANT PROTEINS; TISSUE CULTURE TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745490023     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devcel.2006.04.018     Document Type: Article

References (60)

1. Adelman D.M., Maltepe E., and Simon M.C. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev. 13 (1999) 2478-2483
2. Adelman D.M., Gertsenstein M., Nagy A., Simon M.C., and Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14 (2000) 3191-3203
3. Arai F., Hirao A., and Suda T. Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc. Med. 15 (2005) 75-79
4. Brusselmans K., Bono F., Collen D., Herbert J.M., Carmeliet P., and Dewerchin M. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia. J. Biol. Chem. 280 (2005) 3493-3499
5. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
6. Carmeliet P., and Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190 (2000) 387-405
7. Chan D.A., Sutphin P.D., Denko N.C., and Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277 (2002) 40112-40117
8. Claffey K.P., Shih S.C., Mullen A., Dziennis S., Cusick J.L., Abrams K.R., Lee S.W., and Detmar M. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell 9 (1998) 469-481
9. Compernolle V., Brusselmans K., Acker T., Hoet P., Tjwa M., Beck H., Plaisance S., Dor Y., Keshet E., Lupu F., et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8 (2002) 702-710
10. Coultas L., Chawengsaksophak K., and Rossant J. Endothelial cells and VEGF in vascular development. Nature 438 (2005) 937-945
11. Covello K.L., Simon M.C., and Keith B. Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth. Cancer Res. 65 (2005) 2277-2286
12. Covello K.L., Kehler J., Yu H., Gordan J.D., Arsham A.M., Hu C.J., Labosky P.A., Simon M.C., and Keith B. HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20 (2006) 557-570
13. Cowden Dahl K.D., Fryer B.H., Mack F.A., Compernolle V., Maltepe E., Adelman D.M., Carmeliet P., and Simon M.C. Hypoxia-inducible factors 1α and 2α regulate trophoblast differentiation. Mol. Cell. Biol. 25 (2005) 10479-10491
14. de Bruijn M.F., Ma X., Robin C., Ottersbach K., Sanchez M.J., and Dzierzak E. Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 16 (2002) 673-683
15. Dieterlen-Lievre F., Pardanaud L., Bollerot K., and Jaffredo T. Hemangioblasts and hemopoietic stem cells during ontogeny. C. R. Biol. 325 (2002) 1013-1020
16. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., and Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94 (1997) 4273-4278
17. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
18. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., Hong K., Marsters J.C., and Ferrara N. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
19. Giaccia A.J., Simon M.C., and Johnson R. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev. 18 (2004) 2183-2194
20. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., and Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23 (2003) 9361-9374
21. Ingram D.A., Caplice N.M., and Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106 (2005) 1525-1531
22. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin Jr. W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
23. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., and Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 (1998) 149-162
24. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
25. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9 (2003) 685-693
26. Jain S., Maltepe E., Lu M.M., Simon C., and Bradfield C.A. Expression of ARNT, ARNT2, HIF1 α, HIF2 α and Ah receptor mRNAs in the developing mouse. Mech. Dev. 73 (1998) 117-123
27. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
28. Kopp H.G., Avecilla S.T., Hooper A.T., Shmelkov S.V., Ramos C.A., Zhang F., and Rafii S. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood 106 (2005) 505-513
29. Kotch L.E., Iyer N.V., Laughner E., and Semenza G.L. Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 209 (1999) 254-267
30. Lee Y.M., Jeong C.H., Koo S.Y., Son M.J., Song H.S., Bae S.K., Raleigh J.A., Chung H.Y., Yoo M.A., and Kim K.W. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 220 (2001) 175-186
31. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6 (2000) 1389-1399
32. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
33. Maltepe E., and Simon M.C. Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J. Mol. Med. 76 (1998) 391-401
34. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., and Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386 (1997) 403-407
35. Medvinsky A., and Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86 (1996) 897-906
36. North T.E., de Bruijn M.F., Stacy T., Talebian L., Lind E., Robin C., Binder M., Dzierzak E., and Speck N.A. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16 (2002) 661-672
37. Oike Y., Takakura N., Hata A., Kaname T., Akizuki M., Yamaguchi Y., Yasue H., Araki K., Yamamura K., and Suda T. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93 (1999) 2771-2779
38. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407 (1997) 313-319
39. Peng J., Zhang L., Drysdale L., and Fong G.H. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA 97 (2000) 8386-8391
40. Piret J.P., Mottet D., Raes M., and Michiels C. Is HIF-1α a pro- or an anti-apoptotic protein?. Biochem. Pharmacol. 64 (2002) 889-892
41. Piret J.P., Minet E., Cosse J.P., Ninane N., Debacq C., Raes M., and Michiels C. Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J. Biol. Chem. 280 (2005) 9336-9344
42. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
43. Ramirez-Bergeron D.L., and Simon M.C. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 19 (2001) 279-286
44. Ramirez-Bergeron D.L., Runge A., Dahl K.D., Fehling H.J., Keller G., and Simon M.C. Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131 (2004) 4623-4634
45. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
46. Ryan H.E., Lo J., and Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
47. Sanchez M.-J., Holmes A., Miles C., and Dzierzak E. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 5 (1996) 513-525
48. Semenza G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8 (1998) 588-594
49. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
50. Sowter H.M., Ratcliffe P.J., Watson P., Greenberg A.H., and Harris A.L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61 (2001) 6669-6673
51. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., and Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol. 18 (1998) 3112-3119
52. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
53. Takakura N., Huang X.L., Naruse T., Hamaguchi I., Dumont D.J., Yancopoulos G.D., and Suda T. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9 (1998) 677-686
54. Takakura N., Watanabe T., Suenobu S., Yamada Y., Noda T., Ito Y., Satake M., and Suda T. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102 (2000) 199-209
55. Tang N., Wang L., Esko J., Giordano F.J., Huang Y., Gerber H.P., Ferrara N., and Johnson R.S. Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6 (2004) 485-495
56. Tian H., McKnight S.L., and Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11 (1997) 72-82
57. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., and McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12 (1998) 3320-3324
58. Wang V., Davis D.A., Haque M., Huang L.E., and Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in HEK293T cells. Cancer Res. 65 (2005) 3299-3306
59. Weinstein B.M. What guides early embryonic blood vessel formation?. Dev. Dyn. 215 (1999) 2-11
60. Yu F., White S.B., Zhao Q., and Lee F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98 (2001) 9630-9635